ZBIO
Zenas BioPharma, Inc.Healthcare$21.46
◆ Neutral
Mkt Cap: $1.34B|Float: 35.6M|SI: 21.6%|DTC: 13.0
Data as of market close Apr 2, 2026
IV Rank
0
IV Pctl
0%
HV 20d
92.5%
52W Range
$6-$45
ATR(14)
$2.03
Exp. Move
±11.7%
P/C Ratio
0.59
Earnings
May 14
GEX Negative
DEX Long
Net Call Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
ZBIO Key Options Data
- IV Rank
- 0%
- Total GEX
- $-0.00B
- Total DEX
- $0.2M
- Max Pain
- $20.00
- Expected Move
- ±11.7%
- Put/Call OI
- 0.59
- Net Premium
- $0.1M
- Spot Price
- $21.46
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.50 | ±11.7% | $18.96 | $23.96 |
| 2026-05-15 | 43 | ±$2.60 | ±12.1% | $18.86 | $24.06 |
| 2026-08-21 | 141 | ±$4.55 | ±21.2% | $16.91 | $26.01 |
| 2026-12-18 | 260 | ±$13.75 | ±64.1% | $7.71 | $35.21 |
| 2027-01-15 | 288 | ±$7.40 | ±34.5% | $14.06 | $28.86 |
Explore ZBIO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.